Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status

IMPORTANCE: Accurate blood-based biomarkers for Alzheimer disease (AD) might improve the diagnostic accuracy in primary care, referrals to memory clinics, and screenings for AD trials. OBJECTIVE: To examine the accuracy of plasma β-amyloid (Aβ) and tau measured using fully automated assays together...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmqvist, Sebastian, Janelidze, Shorena, Stomrud, Erik, Zetterberg, Henrik, Karl, Johann, Zink, Katharina, Bittner, Tobias, Mattsson, Niklas, Eichenlaub, Udo, Blennow, Kaj, Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593637/
https://www.ncbi.nlm.nih.gov/pubmed/31233127
http://dx.doi.org/10.1001/jamaneurol.2019.1632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593637/
https://www.ncbi.nlm.nih.gov/pubmed/31233127
http://dx.doi.org/10.1001/jamaneurol.2019.1632

Ejemplares similares